Single-arm trials supporting the approval of anticancer medicinal products in the European Union: contextualization of trial results and observed clinical benefit

por Mulder, J., Teerenstra, S., van Hennik, P.B., Pasmooij, A.M.G., Stoyanova-Beninska, V., Voest, E.E., de Boer, A.
Publicado 2023

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial

por Rodenhuis, S, Bontenbal, M, Beex, LVAM, Smit, WM, Nooij, MA, Voest, EE, Wall, E van der, Hupperets, P, Tinteren, Harm van, Peterse, HL, Vijver, MJ van de, Vries, EGE de
Publicado 2005

Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study()(...

por Snoeren, Nikol, van Hillegersberg, Richard, Schouten, Sander B., Bergman, Andre M., van Werkhoven, Erikv, Dalesio, Otilia, Tollenaar, Rob A.E.M., Verheul, Henk M., van der Sijp, Joost, Borel Rinkes, Inne H.M., Voest, E.E.
Publicado 2017

Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics

por Schipper, L.J., Samsom, K.G., Snaebjornsson, P., Battaglia, T., Bosch, L.J.W., Lalezari, F., Priestley, P., Shale, C., van den Broek, A.J., Jacobs, N., Roepman, P., van der Hoeven, J.J.M., Steeghs, N., Vollebergh, M.A., Marchetti, S., Cuppen, E., Meijer, G.A., Voest, E.E., Monkhorst, K.
Publicado 2022

Prospective experimental treatment of colorectal cancer patients based on organoid drug responses

por Ooft, S.N., Weeber, F., Schipper, L., Dijkstra, K.K., McLean, C.M., Kaing, S., van de Haar, J., Prevoo, W., van Werkhoven, E., Snaebjornsson, P., Hoes, L.R., Chalabi, M., van der Velden, D., van Leerdam, M., Boot, H., Grootscholten, C., Huitema, A.D.R., Bloemendal, H.J., Cuppen, E., Voest, E.E.
Publicado 2021